| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/17/1991 | CN1050680A Process for preparing oral liquid, haicibao |
| 04/17/1991 | CN1050679A Elemental nutrient liquid and preparing process thereof |
| 04/17/1991 | CA2267658A1 Use of stem cell factor polypeptide to stimulate growth of epithelial cells |
| 04/17/1991 | CA2267643A1 Use of stem cell factor polypeptide as an anti-hematopoietic disorder agent |
| 04/17/1991 | CA2267626A1 Use of stem cell factor polypeptide to stimulate growth of stromal cells |
| 04/16/1991 | US5008374 IL-1α derivatives and drugs |
| 04/16/1991 | US5008240 Polypeptide with amino acid sequence of cartilage inducing factor A or B |
| 04/16/1991 | US5008119 Increasing metallothioneim level in host |
| 04/16/1991 | CA1283091C Solid polyvinyl alcohol-based support able to adsorb lipoproteins and its use for the separation of low density lipoproteins present in a liquid, such as blood plasma |
| 04/16/1991 | CA1283073C Adsorbent for purification of blood coagulation factor viii and process for purification of blood coagulation factor viii using the same |
| 04/16/1991 | CA1283048C Therapeutic agent for treating hematopoietic diseases |
| 04/11/1991 | DE3933539A1 Prepn. of an agent to treat minor burns - by baking fresh egg yolk and collecting liq. that separates out from the baked solid |
| 04/10/1991 | EP0421508A2 Sulphated glycosaminoglycuronan with antithrombotic activity |
| 04/10/1991 | EP0421380A1 Tumor-lysing cell inducer, method for inducing tumor-lysing cell and device for inducing tumor-lysing cell |
| 04/10/1991 | EP0420977A1 Novel lyophilized and reconstituted red blood cell compositions |
| 04/09/1991 | US5006512 Charybdotoxin |
| 04/09/1991 | US5006257 Extracts of thermal waters and their applications |
| 04/09/1991 | CA1282786C Glucose tolerance factor and method of making same |
| 04/09/1991 | CA1282725C Process for replicating bone marrow in vitro and using the same |
| 04/09/1991 | CA1282722C Antibiotic tan-749, production and use thereof |
| 04/09/1991 | CA1282695C Methods and materials for treatment of rheumatoid arthritis |
| 04/09/1991 | CA1282694C Agent comprising a plasmin inhibitor and a plasminogen activator for the treatment of thromboses |
| 04/07/1991 | WO1991005536A2 Novel oxidized lipoproteins and methods for their preparation |
| 04/07/1991 | WO1991004744A1 Methods and apparatus for treating disease states using oxidized lipoproteins |
| 04/07/1991 | CA2067364A1 Oxidized lipoproteins and methods for their preparation |
| 04/07/1991 | CA2067356A1 Methods for treating diseases using oxidized lipoproteins |
| 04/04/1991 | WO1991004339A1 Assays and reagents for amyloid deposition |
| 04/04/1991 | WO1991004088A1 Device and method for processing blood for human transfusion |
| 04/04/1991 | WO1991004053A1 Pharmaceutical composition that makes cells expressing mhc class ii antigens targets for cytotoxic t-cells |
| 04/04/1991 | WO1991003935A1 Method and compositions for one-step cryopreservation of embryos |
| 04/04/1991 | WO1991000100A3 Toxin uses |
| 04/04/1991 | DE3931839A1 Neue proteine und ihre herstellung New proteins and their production |
| 04/04/1991 | CA2012101A1 Antiviral medicinal composition |
| 04/03/1991 | EP0419501A1 Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components. |
| 04/02/1991 | US5004808 Aminoalkyl-derivatives of hydroxyalkyl-celluloses |
| 04/02/1991 | US5004805 Hepatocyte growth factor |
| 04/02/1991 | US5004802 100KDa protein from blood which binds to and inhibits the activity of plasminogen activators |
| 04/02/1991 | US5004681 Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood |
| 04/02/1991 | US5004609 Fibrinophilic urokinase complex |
| 04/02/1991 | US5004604 Incubating animal cells with antibodies which coat them, washing, injecting into animal, collecting blood, separating serum |
| 03/30/1991 | CA2025155A1 Extracellular exopolymer, process for its preparation and pharmaceutical compositions containing the said exopolymer |
| 03/29/1991 | WO1991005037A1 Extracellular matrix protein adherent t cells |
| 03/29/1991 | CA2066208A1 Extracellular matrix protein adherent t cells |
| 03/27/1991 | EP0419394A1 Non-digoxin-like Na+,K+-ATPase inhibitory factor |
| 03/27/1991 | EP0419346A2 Filter for purification of platelets |
| 03/27/1991 | EP0419275A1 Flowable demineralized bone powder composition and its use in bone repair |
| 03/27/1991 | CN1050137A Preparation method for pearl liquid from pearl powder |
| 03/26/1991 | WO1991004274A1 Method for inhibiting growth of stem cells |
| 03/26/1991 | WO1991004048A1 Therapeutic agent and method of inhibiting vascularization of tumors |
| 03/26/1991 | US5002071 Sterilized collagen material for injection in humans |
| 03/26/1991 | CA1282020C Proteins for the production of bioadhesives |
| 03/26/1991 | CA1282008C Rapid acting intravenous emulsion of omega-3 fatty acid esters |
| 03/26/1991 | CA1282001C Immunoselection method |
| 03/26/1991 | CA1282000C Immunoselection method |
| 03/24/1991 | WO1991004275A1 New proteins suitable for combating disease and for protecting grazing cattle from ticks |
| 03/24/1991 | CA2054190A1 Proteins suitable for combating disease and for protecting grazing cattle from ticks |
| 03/21/1991 | WO1991004318A1 Cell separation invention |
| 03/21/1991 | WO1991003254A1 Wound healing |
| 03/21/1991 | WO1991003250A1 A method for the treatment of dopaminergic neurodegenerative disorders |
| 03/21/1991 | DE3930510A1 Verfahren zur inaktivierung von viren in blut und blutprodukten A method for inactivation of viruses in blood and blood products |
| 03/20/1991 | EP0417818A1 Selecting amounts of platelet releasate for efficacious treatment of tissue |
| 03/20/1991 | EP0417271A1 Diagnosis and treatment of insulin dependent diabetes mellitus |
| 03/20/1991 | EP0393153A4 Spermatozoa separation method |
| 03/20/1991 | CN1012079B Prepn. for a tonic zhang zhu liquior |
| 03/19/1991 | US5000963 Method of treating the skin using human epidermal sheets |
| 03/19/1991 | US5000953 Biologically active substance |
| 03/19/1991 | CA1281647C Compositions and methods for the treatment of bleeding disorders |
| 03/16/1991 | WO1991004035A1 Selecting amounts of platelet releasate for efficacious treatment of tissue |
| 03/16/1991 | CA2066588A1 Selecting amounts of platelet releasate for efficacious treatment of tissue |
| 03/14/1991 | WO1991003933A1 Process for inactivating viruses in blood and blood products |
| 03/13/1991 | EP0416983A1 Process for the preparation of a concentrate from factor VIII-factor von Willebrand of blood coagulation from the whole plasma |
| 03/13/1991 | EP0416892A1 Agents for the prevention and treatment of diarrhoea |
| 03/13/1991 | EP0416678A1 Topical compositions containing Defibrotide |
| 03/13/1991 | CN1049789A Manufacturing method of musk-toad bolus |
| 03/12/1991 | US4999283 Exposure to antibody in protein-free diluent, suspension, binding to immunoabsorbant substrate |
| 03/12/1991 | US4999202 Humic acid derived from oxidized coal |
| 03/12/1991 | US4999196 Compound DC-107 produced by Streptomyces sp. |
| 03/08/1991 | CA2021874A1 Pharmaceutical composition for topic use for the therapeutical treatment of capillary fragility |
| 03/07/1991 | WO1991002805A2 Recombinant retroviruses delivering vector constructs to target cells |
| 03/07/1991 | WO1991002788A1 Herpes simplex virus type 1 mutant |
| 03/07/1991 | WO1991002458A1 Temperature maintenance of biological or other samples at a selected temperature |
| 03/06/1991 | EP0415731A2 Novel entities for cancer therapy |
| 03/06/1991 | EP0415666A1 Composition for human cell cultivation and use thereof |
| 03/06/1991 | CN1049609A Method for preparing royal jelly products |
| 03/05/1991 | US4997814 Corticosteroid binding globulin and antiinflammatory agent that binds to it |
| 03/05/1991 | US4997443 Reversible gel polymer |
| 03/01/1991 | CA2024122A1 Composition for human cell cultivation and use thereof |
| 03/01/1991 | CA2023435A1 Non-digoxin-like na+, k+-atpase inhibitory factor |
| 02/27/1991 | EP0414404A2 Process for encapsulation of biologicals |
| 02/27/1991 | EP0414304A2 Aqueous antibacterial compositions comprising surfactant and bacteriophage |
| 02/27/1991 | EP0414006A1 Device for selectively removing plasma components from blood |
| 02/26/1991 | WO1991002542A1 Treatment of chronic inflammatory conditions |
| 02/26/1991 | US4996194 Activated lymphocytes having increased antigenic activity; for vaccines |
| 02/26/1991 | US4996159 Purified polypeptides |
| 02/26/1991 | US4996057 Human placental tissue proteins and a condensation product of n-methyl-p-methoxyphenethylamine with formaldehyde; hair growth |
| 02/26/1991 | CA1280721C Bag for separation and isolation of blood components |
| 02/22/1991 | CA2023556A1 Use of viruses against undesirable micro-organisms |
| 02/21/1991 | WO1991002061A1 Recombinant human thyroid peroxidase |
| 02/21/1991 | WO1991001740A1 Process for producing pharmacosmetics |
| 02/21/1991 | WO1991001720A1 Composition and method of promoting hard tissue healing |